Federal Circuit remands Abbott drug test patent suit

14-04-2020

Sarah Morgan

Federal Circuit remands Abbott drug test patent suit

Ken Wolter / Shutterstock.com

The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics. 


US Court of Appeals for the Federal Circuit, Abbott, Alere, Rembrandt Diagnostics, medical devices, patent infringement, claim construction

LSIPR